BioPharma
31 July, 2025 | Thursday | News
AGC Biologics Partners with Valneva to Advance Phase II Shigella Vaccine Supply from Heidelberg Site
AGC Biologics, your friendly CDMO expert, announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply drug subs...
Lab
25 July, 2025 | Friday | News
Eppendorf Launches BioBased Safe-Lock Tubes Made from 100% Renewable Materials
The new generation of Safe-Lock Tubes is finally also biobased. "Eppendorf Safe-Lock Tubes BioBased" are made from 100 % renewable biobased feedstock of second generation (recycled e.g. from food oil wastes and...
BioTech
31 July, 2025 | Thursday | News
South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech
Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-development and license agreement valued at approximately US...
Contract Services
30 July, 2025 | Wednesday | News
WuXi Biologics Begins Construction of One of the World’s Largest Modular Biologics Drug Product Facilities in Singapore
Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats. Finished building will be one of the ...
Consumer Health
31 July, 2025 | Thursday | News
Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the German Center for Neurodegenerative Diseases (DZNE) to deplo...
White Paper
30 July, 2025 | Wednesday | Report
Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)
Product Spot Light
29 July, 2025 | Tuesday | Product Spotlight
Thermo Fisher Launches Heratherm™ Environmental Chamber to Elevate Compliance, Efficiency and Sustainability in Regulated Labs
Premium Article
23 July, 2025 | Wednesday | Opinion
Precision Medicine – Are We Ready for It?
Bio Invest
31 July, 2025 | Thursday | News
South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech
Biopharma APAC Infomercial
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
